AstraZeneca acquires US biotech Omniose

+7.4strongly positive

+7.4

Headlines21

Outlets21

Days311 November – 13 November

Many outlets report AstraZeneca bought vaccine startup Omniose.

Tone by day

Average of each day's headlines, −10 to +10.

Source: MarketFrame news analysis

Tone by day. Average of each day's headlines, −10 to +10. Source: MarketFrame news analysis
day	Average tone
11 Nov	6.7
12 Nov	7.9
13 Nov	7.5

The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

The 10 outlets with the most impact on the tone

Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.

Source: MarketFrame news analysis

The 10 outlets with the most impact on the tone. Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone. Source: MarketFrame news analysis
outlet	Average tone
Pharmaceutical Technology	8.3
EMJ	8.3
The Pharma Letter	8.3
AllSci	8.3
MLQ.ai	8.3
Medical Dialogues	8.3
tokenpost.com	8.3
St. Louis Magazine	8.0
STLtoday.com	8.0
lifesciencesweden.se	8.0

Outlet	Headlines	Average tone
Pharmaceutical Technology	1	+8.3
EMJ	1	+8.3
The Pharma Letter	1	+8.3
AllSci	1	+8.3
MLQ.ai	1	+8.3
Medical Dialogues	1	+8.3
tokenpost.com	1	+8.3
St. Louis Magazine	1	+8.0
STLtoday.com	1	+8.0
lifesciencesweden.se	1	+8.0

All 21 outlets

Outlet	Headlines	Average tone
Hoodline	1	+7.5
Reuters	1	+7.0
FirstWord Pharma	1	+7.0
Fierce Biotech	1	+6.7
Pharmaceutical Executive	1	+6.7
Dealroom	1	+6.7
BioPharm International	1	+6.7
The Business Journals	1	+6.7
Business Wire	1	+6.3
MarketScreener	1	+6.3
Yahoo Finance	1	+5.0

One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.

Tone	What the article reported, and why it scored that way	Source
+7.5	Buys a small biotech, adding to its research capabilities.	Hoodline (opens the article) ↗

AstraZeneca on 13 November

Tone	What the article reported, and why it scored that way	Source
+8.3	Bolt-on deal strengthens bacterial vaccine work.	Pharmaceutical Technology (opens the article) ↗
+8.3	Deal reinforces bacterial vaccine pipeline.	EMJ (opens the article) ↗
+8.3	Vaccine start-up purchase adds pipeline strength.	The Pharma Letter (opens the article) ↗
+8.3	Gains a bioconjugation platform for vaccines.	AllSci (opens the article) ↗
+8.3	Purchase offers simpler route to manufacture conjugate vaccines.	MLQ.ai (opens the article) ↗
+8.3	Acquisition aids vaccines against serious bacterial infections.	Medical Dialogues (opens the article) ↗
+8.3	Acquisition expands its infectious disease and vaccine capabilities.	tokenpost.com (opens the article) ↗
+8.0	Takeover of local vaccine start-up.	St. Louis Magazine (opens the article) ↗

3 more headlines that day

Tone	What the article reported, and why it scored that way	Source
+8.0	Deal for a vaccine developer adds capability.	STLtoday.com (opens the article) ↗
+8.0	Buys vaccine technology firm.	lifesciencesweden.se (opens the article) ↗
+5.0	Vaccine acquisition, alongside a sector-wide safety warning.	Yahoo Finance (opens the article) ↗

AstraZeneca on 12 November

Tone	What the article reported, and why it scored that way	Source
+7.0	Acquisition of US biotech adds to its vaccine pipeline.	Reuters (opens the article) ↗
+7.0	Deal advances its bacterial vaccine research.	FirstWord Pharma (opens the article) ↗
+6.7	Buying existing partner secures bacterial vaccine technology.	Fierce Biotech (opens the article) ↗
+6.7	Takeover adds a bioconjugation technology to vaccine research.	Pharmaceutical Executive (opens the article) ↗
+6.7	Acquisition of vaccine startup expands its vaccine capabilities.	Dealroom (opens the article) ↗
+6.7	Deal brings a bioconjugate vaccine technology platform in-house.	BioPharm International (opens the article) ↗
+6.7	Purchase of a St. Louis vaccine developer strengthens its portfolio.	The Business Journals (opens the article) ↗
+6.3	Target company confirms being bought by AstraZeneca.	Business Wire (opens the article) ↗

1 more headline that day

Tone	What the article reported, and why it scored that way	Source
+6.3	Purchase of US biotech company announced.	MarketScreener (opens the article) ↗

AstraZeneca on 11 November

A short, free morning email on how the news treated AstraZeneca: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

The story

Tone by day

How each outlet covered it · 21 outlets

The 10 outlets with the most impact on the tone

Day by day · 3 days, strongest headlines first

Follow by email